Cargando…
Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy
The retrospective study aimed to investigate the indication for hypertrophy posterior longitudinal ligament (HPLL) removal in anterior decompression for cervical spondylotic myelopathy (CSM). A total of 138 consecutive patients with CSM were divided into 2 groups with developmental cervical stenosis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466216/ https://www.ncbi.nlm.nih.gov/pubmed/28591038 http://dx.doi.org/10.1097/MD.0000000000007043 |
_version_ | 1783243050124836864 |
---|---|
author | Bai, Chengrui Li, Kanghua Guo, Ai Fei, Qi Li, Dong Li, Jinjun Wang, Bingqiang Yang, Yong |
author_facet | Bai, Chengrui Li, Kanghua Guo, Ai Fei, Qi Li, Dong Li, Jinjun Wang, Bingqiang Yang, Yong |
author_sort | Bai, Chengrui |
collection | PubMed |
description | The retrospective study aimed to investigate the indication for hypertrophy posterior longitudinal ligament (HPLL) removal in anterior decompression for cervical spondylotic myelopathy (CSM). A total of 138 consecutive patients with CSM were divided into 2 groups with developmental cervical stenosis (DCS) (group S) and non-DCS (group N), according to the Pavlov ratio. These 2 groups were subdivided into 2 further subgroups, according to whether HPLL was removed or preserved: group SR (49 patients) and group SP (32 patients) in group S, group NR (21 patients) and group NP (36 patients) in group N. The modified Japanese Orthopedic Association score (mJOA), the modified recovery rate (mRR), quality of life (QoL), and relevant clinical data were used for clinical and radiological evaluation. The mJOA scores improved from 7.3 ± 2.2 to 15.0 ± 1.8 in the SR group and from 7.9 ± 2.3 to 14.2 ± 1.5 in the SP group (P = .036), with postoperative QoL significantly higher in the SR group than the SP group. A reduction in the diameter of enlarged spinal canals occurred at a significantly faster rate in the SP group compared with the SR group (P = .002). Multivariate regression analyses showed removal of HPLL correlated with mJOA scores (coefficient = 7.337, P = .002), mRR (%) (coefficient = 9.117, P = .005), PCS (coefficient = 12.129, P < .001), and MCS (coefficient = 14.31, P < .001) in the S group at 24 months postoperatively, while removal of HPLL did not correlate with clinical outcomes in the N group. The HPLL should, therefore, be removed when mobility was reduced and the spinal cord remained compressed after anterior decompression procedures in the patients with DCS. However, in non-DCS patients, it remains unclear as to whether removal of HPLL provides any clinical benefit, thus, HPLL removal may not be necessary. |
format | Online Article Text |
id | pubmed-5466216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-54662162017-06-15 Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy Bai, Chengrui Li, Kanghua Guo, Ai Fei, Qi Li, Dong Li, Jinjun Wang, Bingqiang Yang, Yong Medicine (Baltimore) 7100 The retrospective study aimed to investigate the indication for hypertrophy posterior longitudinal ligament (HPLL) removal in anterior decompression for cervical spondylotic myelopathy (CSM). A total of 138 consecutive patients with CSM were divided into 2 groups with developmental cervical stenosis (DCS) (group S) and non-DCS (group N), according to the Pavlov ratio. These 2 groups were subdivided into 2 further subgroups, according to whether HPLL was removed or preserved: group SR (49 patients) and group SP (32 patients) in group S, group NR (21 patients) and group NP (36 patients) in group N. The modified Japanese Orthopedic Association score (mJOA), the modified recovery rate (mRR), quality of life (QoL), and relevant clinical data were used for clinical and radiological evaluation. The mJOA scores improved from 7.3 ± 2.2 to 15.0 ± 1.8 in the SR group and from 7.9 ± 2.3 to 14.2 ± 1.5 in the SP group (P = .036), with postoperative QoL significantly higher in the SR group than the SP group. A reduction in the diameter of enlarged spinal canals occurred at a significantly faster rate in the SP group compared with the SR group (P = .002). Multivariate regression analyses showed removal of HPLL correlated with mJOA scores (coefficient = 7.337, P = .002), mRR (%) (coefficient = 9.117, P = .005), PCS (coefficient = 12.129, P < .001), and MCS (coefficient = 14.31, P < .001) in the S group at 24 months postoperatively, while removal of HPLL did not correlate with clinical outcomes in the N group. The HPLL should, therefore, be removed when mobility was reduced and the spinal cord remained compressed after anterior decompression procedures in the patients with DCS. However, in non-DCS patients, it remains unclear as to whether removal of HPLL provides any clinical benefit, thus, HPLL removal may not be necessary. Wolters Kluwer Health 2017-06-08 /pmc/articles/PMC5466216/ /pubmed/28591038 http://dx.doi.org/10.1097/MD.0000000000007043 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 7100 Bai, Chengrui Li, Kanghua Guo, Ai Fei, Qi Li, Dong Li, Jinjun Wang, Bingqiang Yang, Yong Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title | Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title_full | Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title_fullStr | Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title_full_unstemmed | Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title_short | Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
title_sort | indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy |
topic | 7100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466216/ https://www.ncbi.nlm.nih.gov/pubmed/28591038 http://dx.doi.org/10.1097/MD.0000000000007043 |
work_keys_str_mv | AT baichengrui indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT likanghua indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT guoai indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT feiqi indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT lidong indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT lijinjun indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT wangbingqiang indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy AT yangyong indicationforhypertrophyposteriorlongitudinalligamentremovalinanteriordecompressionforcervicalspondyloticmyelopathy |